How the dystrophin protein helps brain cells form connections

The Role of Dystrophin in Synapse Development

NIH-funded research University of Texas Hlth Science Center · NIH-11159772

Looks at whether missing dystrophin disrupts how inhibitory brain connections mature, which could help explain learning and behavior differences in people with Duchenne muscular dystrophy.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Texas Hlth Science Center NIH-funded
Lab location1 site (San Antonio, United States)
Project IDNIH-11159772 on NIH RePORTER

What this research studies

This project studies dystrophin, a protein missing in Duchenne muscular dystrophy, to learn how it helps inhibitory synapses form and mature in the brain. Researchers will use laboratory models that lack dystrophin and compare them with normal controls to examine synapse structure and signaling, focusing on cerebellar Purkinje cells and GABAA receptor clustering. The team will probe the dystrophin glycoprotein complex and its interactions with presynaptic partners to identify why inhibitory connections are reduced or remain immature without dystrophin. Findings are intended to reveal biological steps that could become targets for treatments to improve cognition and behavior in affected people.

Who could benefit from this research

Good fit: People with Duchenne muscular dystrophy (including adults) who experience cognitive, attention, or autism-like symptoms would be the most relevant group for this research.

Not a fit: Individuals whose conditions are not related to dystrophin mutations (other causes of ADHD or ASD) or those seeking immediate clinical treatments are unlikely to receive direct benefit from this basic science project.

Why it matters

Potential benefit: If successful, this work could explain why people with Duchenne muscular dystrophy have cognitive and neurodevelopmental symptoms and point to targets for therapies to improve brain function.

How similar studies have performed: Previous animal studies have shown that loss of dystrophin reduces inhibitory synapse number and links to behavioral deficits, but directly targeting synapse maturation is a newer and evolving area.

Where this research is happening

San Antonio, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Attention deficit hyperactivity disorderAutistic Disorder
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.